Michal Ayalon
Nessuna posizione attualmente
Profilo
Michal Ayalon worked as Vice President of Research and Development at Kamada Ltd.
from 2019 to 2022.
Prior to that, she held the same position at Galmed Pharmaceuticals Ltd.
in 2015-2016.
In 2018-2019, she was Head of Research and Development at 89Bio Ltd.
Ayalon received her undergraduate, graduate, and doctorate degrees from Tel-Aviv University.
Precedenti posizioni note di Michal Ayalon
| Società | Posizione | Fine |
|---|---|---|
| KAMADA LTD. | Direttore Tecnico/Scientifico/R&S | 28/02/2022 |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Direttore Tecnico/Scientifico/R&S | 01/01/2019 |
| GALMED PHARMACEUTICALS LTD. | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Formazione di Michal Ayalon
| Tel-Aviv University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| GALMED PHARMACEUTICALS LTD. | Health Technology |
| KAMADA LTD. | Health Technology |
| Aziende private | 1 |
|---|---|
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Health Technology |
- Borsa valori
- Insiders
- Michal Ayalon